Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric Cancer Congress
Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing… Read More »
Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma
– The novel bispecific antibody ATG-101 is Antengene’s first in house developed molecule with global rights. – This approval in China marks… Read More »
Nature Research Custom Media: SHAPING THE FUTURE OF OMICS FOR ALL
Nature Research Custom Media published a feature story “Shaping the Future of Omics for All” about BGI Genomics, showcasing how… Read More »
Everlife acquires Research Instruments Group and other laboratory suppliers to boost presence in strategic life sciences and clinical diagnostics segments in South East Asia
Everlife Holdings Pte Ltd (“Everlife”), a leading market access and distribution company in India and South East Asia, has announced… Read More »
Everest Medicines Announces that Licensing Partner Venatorx Pharmaceuticals Reports Positive Results from Pivotal Phase 3 Cefepime-Taniborbactam Trial
Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Venatorx Pharmaceuticals, reported positive results from its pivotal Phase 3… Read More »
Pulnovo Medical Appoints Ms. Jessie Lian Jia as New CEO
Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced the appointment of Ms. Jessie Lian Jia as Chief… Read More »
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022
Gracell to present first-in-human data on GC502, an allogeneic CD19/CD7 dual-directed chimeric antigen receptor (CAR) T cell therapy Gracell Biotechnologies… Read More »
ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer
ProfoundBio announced that preclinical data from its pipeline of novel, proprietary antibody-drug conjugates (ADCs) and technology will be presented at… Read More »
Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related… Read More »
Alphamab Oncology to Present Clinical Data of KN026 Combined with KN046 in HER2-positive Solid Tumors at AACR 2022
Alphamab Oncology (stock code: 9966.HK) announced that data from phase II clinical study (KN026-203) of KN026 (HER2 bispecific antibody) combined… Read More »